Skip to main content

Table 1 The demographic and clinical baseline of ADD and Controls

From: Potential value of gastrointestinal myoelectrical activity in the diagnosis of anxiety-depression disorder: a population-based study

 

ADD

(n = 91)

Controls

(n = 586)

Test value

P

Age

56.48 ± 6.70

55.87 ± 6.66

0.819 a

0.309

Gender (male, %)

21(23.08%)

185(31.57%)

2.684c

0.101

Body mass index

23.71 ± 2.92

24.35 ± 3.11

1.817 a

0.070

Smoke (yes, %)

11(12.09%)

77(13.14%)

0.077 c

0.781

Alcohol (yes, %)

14(15.38%)

148(25.26%)

4.217 c

0.040

PHQ-9 score

5.66 ± 4.49

0.6 ± 1.15

-14.354 b

< 0.001

GAD-7 score

5.87 ± 3.83

0.37 ± 0.88

-16.340 b

< 0.001

Glucose

5.28 ± 1.11

5.52 ± 1.39

1.577 a

0.115

Triglyceride

1.52 ± 0.80

1.65 ± 1.38

0.865 a

0.387

Total cholesterol

5.38 ± 1.02

5.38 ± 0.94

0.018 a

0.985

High-density lipoprotein

1.78 ± 0.51

1.75 ± 0.49

0.544 a

0.587

Low-density lipoprotein

3.00 ± 0.74

3.01 ± 0.69

0.060 a

0.952

  1. Note: a refers to ‘t’ value from Student’s t-tests; b refers to ‘Z’ value from Mann-Whitney U-tests; c refers to ‘X2’ value from Chi-square analysis. ADD, anxiety-depression disorders